Transcutaneous auricular vagus nerve stimulation in poststroke cognitive impairment: protocol for a randomised controlled trial.

ABSTRACT:

Background

As one of the most common stroke sequelae, poststroke cognitive impairment significantly impacts 17.6%-83% of survivors, affecting their rehabilitation, daily living and quality of life. Improving cognitive abilities among patients in stroke recovery is therefore critical and urgent. Transcutaneous auricular vagus nerve stimulation (TAVNS) is a non-invasive, safe, cost-effective treatment with great potential for improving the cognitive function of poststroke patients. This clinical research will evaluate the effectiveness, and help elucidate the possible underlying mechanisms, of TAVNS for improving poststroke cognitive function.

Methods and analysis

A single-centre, parallel-group, allocation concealment, assessor-blinded randomised controlled clinical trial. We

SUBMITTER: Li ZD 

PROVIDER: S-EPMC9535199 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature